Media coverage

Biotechfinances – 15h Biotech express

https://www.eei-biotechfinances.com/15h-biotech-express-enyo-pharma-neon-therapeutics-tricares-ipsen-innate-pharma-sensorion-safe-orthopaedics-oxivax

Published on 05/06/2018

Les Echos, Capital Finance – La biotech Enyo Pharma sécurise 40 M€ pour sa série B

https://capitalfinance.lesechos.fr/deals/capital-risque/la-biotech-enyo-pharma-securise-40-m-pour-sa-serie-b-127458

Published on 05/06/2018

Le Figaro – Pharmacie: Enyo lève 40 millions d’euros

http://www.lefigaro.fr/flash-eco/2018/06/04/97002-20180604FILWWW00190-pharmacie-enyo-leve-40-millions-d-euros.php

Published on 05/06/2018

Challenges – Levée de fonds record pour Enyo Pharma, la biotech lyonnaise qui s’attaque à la malbouffe

https://www.challenges.fr/start-up/levee-de-fonds-record-pour-enyo-pharma-la-biotech-lyonnaise-qui-s-attaque-a-la-malbouffe_591696

Published on 04/06/2018

Le Progrès – Enyo Pharma lève 40 millions d’euros

https://www.leprogres.fr/economie/2018/06/04/enyo-pharma-leve-40-millions-d-euros

Published on 04/06/2018

News

Latest Press Release

ENYO Pharma announces a €39 million Series C financing and FDA clearance to advance Vonafexor in a Phase 2 clinical trial for patients with Alport syndrome.
ENYO Pharma announ...

> Read more